BioLife Sciences Inc
BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.
BioLife Sciences Inc (BLFE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of February 2022: 0.018x
Based on the latest financial reports, BioLife Sciences Inc (BLFE) has a cash flow conversion efficiency ratio of 0.018x as of February 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.96) by net assets ($-109.57). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioLife Sciences Inc - Cash Flow Conversion Efficiency Trend (2004–2020)
This chart illustrates how BioLife Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioLife Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioLife Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beard Co
PINK:BRCOQ
|
0.096x |
|
Infusion Brands International Inc
PINK:INBI
|
0.034x |
|
Montague International Holding Ltd
PINK:MIHL
|
-0.001x |
|
Hybrid Energy Holdin
PINK:HYBE
|
0.007x |
|
Novation Hldgs Inc.
PINK:NOHO
|
0.000x |
|
EPIC Corp
PINK:EPOR
|
0.001x |
|
RBC Life Sciences Inc
PINK:RBCL
|
-0.012x |
|
Liberty International Holding Corp
PINK:PDPG
|
N/A |
Annual Cash Flow Conversion Efficiency for BioLife Sciences Inc (2004–2020)
The table below shows the annual cash flow conversion efficiency of BioLife Sciences Inc from 2004 to 2020.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-11-30 | $-689.58K | $-884.31K | 1.282x | +8805.10% |
| 2019-11-30 | $-1.15K | $17.00 | -0.015x | -125.99% |
| 2018-11-30 | $-220.87K | $-12.52K | 0.057x | -44.30% |
| 2017-11-30 | $-183.10K | $-18.63K | 0.102x | +102.12% |
| 2007-11-30 | $59.59K | $-285.42K | -4.790x | -3085.19% |
| 2006-11-30 | $250.44K | $-37.66K | -0.150x | +92.11% |
| 2005-11-30 | $27.83K | $-53.02K | -1.905x | -378.39% |
| 2004-11-30 | $69.95K | $-27.86K | -0.398x | -- |